This episode is part of ACC's ongoing initiative to recognize the risks and tackle management of Hypertriglyceridemia (HTG) and Severe Hypertriglyceridemia (sHTG). Drs. Michael Miller and Monica Aggarwal review and emphasize the need to understand the multifactorial and genetic causes of HTG and sHTG, as well as the associated risks of pancreatitis and ASCVD.

This podcast is part of the ACC's Hypertriglyceridemia and Cardiovascular Health: Recognizing Risks and Tackling Management initiative, supported by Ionis Pharmaceuticals.

This episode is part of ACC's ongoing educational initiative to enhance the recognition, diagnosis, and management of paroxysmal supraventricular tachycardia (PSVT). Faculty review contemporary acute treatment approaches, including established therapies, recent advances, and first-line emergency department strategies with attention to efficacy and safety. The discussion also addresses management of refractory or recurrent cases, decision-making across diverse patient populations and care settings, and criteria for hospital admission versus discharge. Additionally, it provides practical guidance on patient education, symptom recognition, and selecting treatments that balance effectiveness, safety, convenience, and patient confidence.

This podcast is part of the ACC's educational initiative on PSVT, supported by an independent educational grant from Milestone Pharmaceuticals Inc. Click here to learn more.

This episode provides a team-based overview of diagnosing and managing acute paroxysmal supraventricular tachycardia (PSVT) across care settings. It emphasizes how patients interact with providers from primary care to electrophysiology and the importance of coordinated roles. The discussion highlights shared decision-making and targeted education to help patients recognize symptoms, understand recurrence risk, and respond to episodes. Key topics include when to seek care, initial self-management steps, and long-term options such as medication, ablation, or observation. It also reviews practical action plans and the role of newer therapies like intranasal etripamil in individualized care.

This podcast is part of the ACC's educational initiative on PSVT, supported by an independent educational grant from Milestone Pharmaceuticals Inc. Click here to learn more: https://learn.acc.org/Page/LearnSVT